Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling
- PMID: 31367523
- PMCID: PMC6646740
- DOI: 10.1016/j.ymgmr.2019.100495
Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling
Abstract
Gangliosidoses, including GM1-gangliosidosis and GM2-gangliosidosis (Tay-Sachs disease and Sandhoff disease), are lysosomal disorders resulting from enzyme deficiencies and accumulation of gangliosides. Phenotypes of gangliosidoses range from infantile, late-infantile, juvenile, and to the adult form. The genotype-phenotype correlation is essential for prognosis and clinical care planning for patients with a gangliosidosis condition. Previously, we have developed a method to establish the genotype-phenotype correlation of another lysosomal disease, mucopolysaccharidosis type I, with in silico tools. This same method was applied to analyze the genotype and phenotype of 38 patients diagnosed with a gangliosidosis disease in the United States. Out of 40 mutations identified, 3 were novel, including p.Tyr192His and p.Phe556Ser of the GLB1 gene and p.Gly461Val of the HEXA gene. Furthermore, the mutant protein structure of all missense mutations was constructed by homology modeling. A systemic structural analysis of these models revealed the specific mechanisms of how each mutation may lead to the disease. In summary, the method developed in this study holds promise as a tool that can be broadly applicable to other lysosomal diseases and monogenic diseases.
Keywords: Disease subtype; Gangliosidosis; Genotype-phenotype correlation; In silico; Lysosomal disorder.
Figures


Similar articles
-
Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.Mol Genet Metab. 2018 Feb;123(2):97-104. doi: 10.1016/j.ymgme.2017.12.432. Epub 2017 Dec 20. Mol Genet Metab. 2018. PMID: 29352662 Free PMC article.
-
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.Pediatrics. 2006 Nov;118(5):e1550-62. doi: 10.1542/peds.2006-0588. Epub 2006 Oct 2. Pediatrics. 2006. PMID: 17015493 Free PMC article. Review.
-
Chitotriosidase as a biomarker for gangliosidoses.Mol Genet Metab Rep. 2021 Oct 1;29:100803. doi: 10.1016/j.ymgmr.2021.100803. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34646735 Free PMC article.
-
Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.Mol Genet Metab. 2015 Feb;114(2):274-80. doi: 10.1016/j.ymgme.2014.11.015. Epub 2014 Dec 6. Mol Genet Metab. 2015. PMID: 25557439 Free PMC article.
-
[Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].Yakugaku Zasshi. 2013;133(2):269-74. doi: 10.1248/yakushi.12-00199. Yakugaku Zasshi. 2013. PMID: 23370522 Review. Japanese.
Cited by
-
Juvenile Tay Sachs Disease Due to Compound Heterozygous Mutation in Hex-A Gene, with Early Sign of Bilateral Tremors.Ann Indian Acad Neurol. 2022 May-Jun;25(3):502-505. doi: 10.4103/aian.aian_577_21. Epub 2022 Jan 5. Ann Indian Acad Neurol. 2022. PMID: 35936646 Free PMC article. No abstract available.
-
A comprehensive update of genotype-phenotype correlations in PMM2-CDG: insights from molecular and structural analyses.Orphanet J Rare Dis. 2025 Apr 30;20(1):207. doi: 10.1186/s13023-025-03669-5. Orphanet J Rare Dis. 2025. PMID: 40307862 Free PMC article. Review.
-
Late-infantile GM1 gangliosidosis: A case report.Medicine (Baltimore). 2022 Jan 7;101(1):e28435. doi: 10.1097/MD.0000000000028435. Medicine (Baltimore). 2022. PMID: 35029890 Free PMC article.
-
A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.Gene Ther. 2020 May;27(5):226-236. doi: 10.1038/s41434-019-0120-5. Epub 2020 Jan 2. Gene Ther. 2020. PMID: 31896760 Free PMC article.
-
Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis.Mol Genet Metab Rep. 2025 Jan 20;42:101191. doi: 10.1016/j.ymgmr.2025.101191. eCollection 2025 Mar. Mol Genet Metab Rep. 2025. PMID: 39897471 Free PMC article.
References
-
- Sarafoglou K., Hoffmann G.F., Roth K.S. McGraw-Hill Company; New York: 2009. Pediatric Endocrinology and Inborn Errors of Metabolism; pp. 738–739. (& 744–745)
-
- Callahan J.W. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Biochim. Biophys. Acta. 1999;1455:85–103. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources